Buy This Pharma Stock, Trading 2% Away From 52-Week Low, For 57% Gain: Motilal Oswal

Motilal Oswal has recommended investors to buy small cap Pharmaceuticals sector stock, Gland Pharma Ltd with a target price of Rs 2660 apiece. The current market price of Gland Pharma is Rs 1693 apiece. The company has a market capitalisation of Rs 27,892.45 crore. Check key takeaways below:

1. Gland Pharma Ltd Stock Outlook

The current market price of the stock is Rs 1693 apiece with a 52-week high at Rs 4060 apiece and 52-week low at Rs 1660 apiece, respectively.

2. Gland Pharma Ltd Return

The stock has fallen 6% in last 5-years, 52% in last 1-year, 38% in last 6-months, and 29% in last 3-months.

3. Gland Pharma Ltd Quarterly Results

The pharma company was incorporated in 1978 and declared its latest quarterly results as on September 30, 2022. The consolidated total income was declared at Rs 1110 crore, up 19% from last quarter total income of Rs 931 crore. The company declared net profit after tax at Rs 241 crore in latest quarter.

4. Gland Pharma Ltd About

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer [HK1] of small volume liquid parenteral products, to become one of the largest and fastest growing generic injectables manufacturing companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets, according to its official website.

Disclaimer

The stock has been picked from the brokerage report of Motilal Oswal. Greynium Information Technologies, the Author, and the respective Brokerage House are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.